News Shortcuts from other journals

Oral vaccine protects European infants from rotavirus gastroenteritis

BMJ 2007; 335 doi: (Published 29 November 2007) Cite this as: BMJ 2007;335:1119

Rotarix is GlaxoSmithKline's oral vaccine against rotavirus infections. It worked well in Latin America, and the company has now completed a large phase III trial in nearly 4000 infants in Europe. Two doses of the vaccine given with other routine vaccinations reduced rotavirus …

View Full Text

Log in

Log in through your institution


* For online subscription